Fuse Vectors Revenue and Competitors
Estimated Revenue & Valuation
- Fuse Vectors's estimated annual revenue is currently $2.3M per year.
- Fuse Vectors's estimated revenue per employee is $155,000
Employee Data
- Fuse Vectors has 15 Employees.
- Fuse Vectors grew their employee count by 50% last year.
Fuse Vectors's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-CEO, CSO and Co-Founder | Reveal Email/Phone |
2 | Senior Scientist Virology | Reveal Email/Phone |
3 | Protein Scientist | Reveal Email/Phone |
4 | Business Developer | Reveal Email/Phone |
5 | Principal technician | Reveal Email/Phone |
Fuse Vectors Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.3M | 15 | 50% | N/A | N/A |
#2 | $2.6M | 17 | 0% | $31M | N/A |
#3 | $1.1M | 7 | 75% | N/A | N/A |
#4 | $4.8M | 31 | 7% | $57.9M | N/A |
#5 | $4.2M | 27 | 4% | $31.3M | N/A |
#6 | $4M | 26 | 24% | $22.8M | N/A |
#7 | $11.5M | 74 | 19% | N/A | N/A |
#8 | $7.6M | 40 | 90% | $134M | N/A |
#9 | $6M | 32 | 39% | $490M | N/A |
What Is Fuse Vectors?
At Fuse Vectors, our mission is to revolutionize AAV gene therapy development. Traditional cell-based technologies have hindered progress, posing challenges in safety, efficacy, development time, and cost. Our Cell-Free AAV technology surpasses these methods, producing safer, more effective, and cost-efficient AAV viral vectors in a fraction of the time.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Copenhagen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 15 | -12% | N/A |
#2 | $2.3M | 15 | -6% | N/A |
#3 | $7.5M | 17 | -26% | N/A |
#4 | $2.6M | 17 | 0% | $31M |
#5 | $3.6M | 17 | 0% | N/A |